News
-
Pre-announcement: Twinning Call 2026
The Twinning Call 2026 is designed to accelerate the implementation of personalised medicine solutions or approaches from one country to another through peer-to-peer exchanges. This call offers up to 50,000 EUR to activities that facilitate the exchange of solutions or approaches in personalised medicine and build up the capacities and capabilities of one or both participating parties.
-
Winner of EP PerMed’s JTC2022 Video Competition
The winner of the JTC2022 video competition is the team of young researchers of the DAWN-AF consortium with the video ‘Digital Twins to Treat Atrial Fibrillation’.
-
ICPerMed Webinar on International Personalised Medicine Perspectives – Recordings available
ICPerMed organised a webinar on international perspectives on personalised medicine on 25 September 2025. Recordings featuring Daryl Pritchard (Personalized Medicine Coalition, USA) and Mohamed Zahir Alimohamed (Tanzania Human Genetics Organisation, Tanzamia) are now available.
-
Call Announcement: RITC2026 – Test and Demonstration of Multimodal Data Approaches for Personalised Medicine
EP PerMed has launched its first research, innovation and technology call (RITC2026) for proposals on “Test and Demonstration of Multimodal Data Approaches for Personalised Medicine”, acronym “MultiPMData2026”. In total, 19 funding organisations participate in this call with an available budget of over 14.8 Mio. € (approx.).
EP PerMed RITC2026
Test and Demonstration of Multimodal Data Approaches for Personalised Medicine
EP PerMed will fund innovation projects in human health that focus on multimodal data usage for personalised medicine approaches providing more efficient and personalised management of patients with multimorbidity, having at least two chronic diseases that require management
Citizen Awareness of Personalised Medicine
Your opinion matters!
Have you been involved in a personalised treatment or are you aware of personalised medicine approaches?
EP PerMed likes to understand how well people are informed about personalised medicine, how they perceive it, and their thoughts on its potential benefits and challenges.
The anonymous survey contains 36 questions and takes approximately 10-15 minutes to complete. It is currently available in: English, Czech, Danish, Finnish, French, German, Greek, Italian, Norwegian, Dutch, Polish, Portuguese, Romanian, Spanish, Swedish and Turkish.
Mission & Objectives
Governance & Boards
The European Partnership for Personalised Medicine gathers together around 60 partners from 25 countries. The Consortium is managed by a so-called Coordination Unit (CU) and General Assembly (GeA). The day-to-day business, planning and implementation of activities is realized through five Work Packages. The EP PerMed overarching Advisory Bodies are ICPerMed, an Advisory Board and a Stakeholder Forum.